The leadership of the Pharmaceutical Society of Nigeria engages DP World in high-level discussions focused on strategic collaboration, conference participation, and long-term partnership opportunities within Nigeria’s pharmaceutical and healthcare value chain.

On Thursday, 12th February 2026, the leadership of the Pharmaceutical Society of Nigeria (PSN) paid a strategic courtesy visit to WWCV, a subsidiary of DP World, in a move aimed at strengthening institutional collaboration and deepening private-sector engagement within Nigeria’s pharmaceutical and healthcare ecosystem.

The high-powered delegation was led by the President of PSN and accompanied by the Deputy President (South) and other distinguished members of the National Executive Council. They were warmly received by the Managing Director and Pharm. Victor, alongside members of the DP World management team, reflecting the mutual respect and institutional regard shared by both organisations.

Focus on Strategic Partnership and Conference Engagement

Discussions during the visit were robust and forward-looking, centering on three key pillars: strategic collaboration between PSN and DP World; conference planning and participation; and prioritisation of partnership opportunities.

Both parties explored avenues for structured engagement that would enhance pharmaceutical supply chain efficiency, support healthcare delivery systems, and create value across the broader logistics and health value chain. Given DP World’s global footprint and its representation of over 40 companies within its ecosystem, conversations highlighted the importance of aligning pharmaceutical distribution, port operations, and logistics infrastructure with national health priorities.




DP World Signals Strong Conference Presence

A major highlight of the engagement was DP World’s expressed commitment to expanding its presence and participation at the upcoming PSN National Conference. The company indicated its intention to “turn big” for the conference, signalling readiness for increased visibility, deeper engagement, and strategic investment in partnership platforms.

DP World requested prioritisation in partnership considerations, underscoring its recognition of PSN as a critical stakeholder within Nigeria’s pharmaceutical and healthcare landscape.

Commendation for PSN’s Leadership and Impact

Members of the DP World management team commended PSN for its strides, institutional reforms, and sustained advocacy efforts within the pharmaceutical profession. Particular note was made of PSN’s expanding influence in policy dialogue, professional development, and healthcare system strengthening across Nigeria.

The visit also provided an opportunity to reflect on the evolving role of pharmacists—not only as healthcare providers but as essential actors in supply chain governance, medicines access, regulatory compliance, and public health leadership.


Goodwill and Commitment to Sustained Collaboration

As a gesture of goodwill and appreciation, gifts were presented to the PSN delegation, symbolising the spirit of partnership and shared purpose that characterised the engagement.

The meeting concluded with a formal vote of thanks, reaffirming the mutual commitment of both organisations to sustained collaboration, innovation-driven partnership, and shared growth in advancing Nigeria’s pharmaceutical and healthcare objectives.

About This Report

This article was compiled from official briefings and communications issued by the Office of the President of the Pharmaceutical Society of Nigeria (PSN) following the strategic courtesy visit to WWCV, a DP World company. The report reflects verified accounts of the discussions, resolutions, and goodwill exchanges that took place during the engagement.